266 related articles for article (PubMed ID: 30578870)
1. 17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.
Wheeler JC; Vanoni S; Zeng C; Waggoner L; Yang Y; Wu D; Uddin J; Karns R; Kottyan L; Mukkada V; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2019 Jun; 143(6):2131-2146. PubMed ID: 30578870
[TBL] [Abstract][Full Text] [Related]
2. IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
Marella S; Sharma A; Ganesan V; Ferrer-Torres D; Krempski JW; Idelman G; Clark S; Nasiri Z; Vanoni S; Zeng C; Dlugosz AA; Zhou H; Wang S; Doyle AD; Wright BL; Spence JR; Chehade M; Hogan SP
J Allergy Clin Immunol; 2023 Dec; 152(6):1550-1568. PubMed ID: 37652141
[TBL] [Abstract][Full Text] [Related]
3. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
[TBL] [Abstract][Full Text] [Related]
4. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction.
Wu L; Oshima T; Li M; Tomita T; Fukui H; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G341-G350. PubMed ID: 29746170
[TBL] [Abstract][Full Text] [Related]
5. LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium.
D'Mello RJ; Caldwell JM; Azouz NP; Wen T; Sherrill JD; Hogan SP; Rothenberg ME
Mucosal Immunol; 2016 May; 9(3):744-56. PubMed ID: 26462420
[TBL] [Abstract][Full Text] [Related]
6. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
Vanoni S; Zeng C; Marella S; Uddin J; Wu D; Arora K; Ptaschinski C; Que J; Noah T; Waggoner L; Barski A; Kartashov A; Rochman M; Wen T; Martin L; Spence J; Collins M; Mukkada V; Putnam P; Naren A; Chehade M; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2020 Jan; 145(1):239-254.e2. PubMed ID: 31647967
[TBL] [Abstract][Full Text] [Related]
7. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
[TBL] [Abstract][Full Text] [Related]
8. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
Shoda T; Wen T; Caldwell JM; Ben-Baruch Morgenstern N; Osswald GA; Rochman M; Mack LE; Felton JM; Abonia JP; Arva NC; Atkins D; Bonis PA; Capocelli KE; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Putnam PE; Rudman Spergel AK; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME;
Gastroenterology; 2022 Feb; 162(2):439-453. PubMed ID: 34687736
[TBL] [Abstract][Full Text] [Related]
9. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.
Manresa MC; Chiang AWT; Kurten RC; Dohil R; Brickner H; Dohil L; Herro R; Akuthota P; Lewis NE; Croft M; Aceves SS
Gastroenterology; 2020 Nov; 159(5):1778-1792.e13. PubMed ID: 32712105
[TBL] [Abstract][Full Text] [Related]
10. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.
Nguyen N; Fernando SD; Biette KA; Hammer JA; Capocelli KE; Kitzenberg DA; Glover LE; Colgan SP; Furuta GT; Masterson JC
Mucosal Immunol; 2018 Mar; 11(2):415-426. PubMed ID: 28832026
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13.
Niranjan R; Rayapudi M; Mishra A; Dutt P; Dynda S; Mishra A
Immunol Cell Biol; 2013 Jul; 91(6):408-15. PubMed ID: 23689305
[TBL] [Abstract][Full Text] [Related]
14. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
15. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice.
Venturelli N; Lexmond WS; Ohsaki A; Nurko S; Karasuyama H; Fiebiger E; Oyoshi MK
J Allergy Clin Immunol; 2016 Nov; 138(5):1367-1380.e5. PubMed ID: 27233150
[TBL] [Abstract][Full Text] [Related]
16. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
[TBL] [Abstract][Full Text] [Related]
17. CD73
Hara T; Kasagi Y; Wang J; Sasaki M; Aaron B; Karami A; Shimonosono M; Shimonosono R; Maekawa H; Dolinsky L; Wilkins B; Klein J; Wei J; Nunes K; Lynch K; Spergel JM; Hamilton KE; Ruffner MA; Karakasheva TA; Whelan KA; Nakagawa H; Muir AB
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1449-1467. PubMed ID: 35108658
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.
Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS
J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082
[TBL] [Abstract][Full Text] [Related]
19. Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis.
Cho JY; Rosenthal P; Miller M; Pham A; Aceves S; Sakuda S; Broide DH
Int Immunopharmacol; 2014 Jan; 18(1):35-42. PubMed ID: 24239745
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
